Anandan Palani

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

Alexandra Trkola, Shawn E. Kuhmann, Julie Strizki et al. · Proceedings of the National Academy of Sciences · 2002 · 304 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection <i>in vitro</i> and <i>in vivo</i>

Julie Strizki, Serena Xu, Nicole Wagner et al. · Proceedings of the National Academy of Sciences · 2001 · 300 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Interaction of small molecule inhibitors of HIV-1 entry with CCR5

Christoph Seibert, Weiwen Ying, Svetlana Gavrilov et al. · Virology · 2006 · 121 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

A method for the selective oxidation of 1,4-diols to lactols

E. J. Corey, Anandan Palani · Tetrahedron Letters · 1995 · 110 citations

Natural Sciences, Chemistry, Organic Chemistry +4

Discovery of 4-[(<i>Z</i>)-(4-Bromophenyl)- (ethoxyimino)methyl]-1‘-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4‘-methyl-1,4‘- bipiperidine <i>N</i>-Oxide (SCH 351125):  An Orally Bioavailable Human CCR5 Antagonist for the Treatment of HIV Infection

Anandan Palani, Sherry Shapiro, John W. Clader et al. · Journal of Medicinal Chemistry · 2001 · 95 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17